Charles River Lab (CRL) - Multiplikator Forward P/S

Tandha merek Charles River (CRL)

Charles River Laboratories (CRL) revenues depend on venture capital infusions into biotech startups, which creates moderate volatility in cash flows. An analysis of the future EV/Revenue multiple on the GURU.Markets chart demonstrates valuation dynamics, where the value 0.30 shows the current figure. The business foundation is based on unique laboratory models and rigorous standards, guaranteeing customer loyalty and global leadership in the preclinical sector.

CRL Charles River: Rega forward marang dodolan ing interval 04.07.2022 - 13.11.2026

CRL (Charles River Corp): rincian analitis lan laporan miturut indikator

- rega saiki lan proyeksi nilai saham:
Rega saham Charles River|CRL - Konsensus nilai wajar
- indikator kapitalisasi pasar:
Kapitalisasi pasar Charles River Corp|CRL - Nilai Perusahaan
- statistik nilai buku emiten:
Aset Bersih saben Siji Saham Charles River|CRL - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku criver.com|CRL - Aset Agregat Perusahaan
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Charles River Laboratories|CRL - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Charles River Laboratories|CRL - Gunggung kewajiban utang perusahaan|Utang marang nilai buku Charles River Corp|CRL - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Charles River|Rasio cepet criver.com
- data bathi bisnis lan rasio investasi:
CRL - Asil keuangan resik|Bathi mangsa ngarep Charles River Laboratories|CRL - Rasio rega marang bathi|Pangali Forward P/E Charles River Lab|CRL - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Charles River Corp|CRL - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Charles River|CRL - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan criver.com|CRL - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Charles River Laboratories
- statistik dodolan lan pendapatan perusahaan:
CRL - Pendapatan lan volume dodolan|Prakiraan volume dodolan Charles River|CRL - Rasio rega marang pendapatan|Rasio rega marang prakiraan pendapatan Charles River Corp
Analisis komprehensif perusahaan:Charles River (CRL)
Sampel barang Charles River Laboratories

Charles River Laboratories (CRL) leadership in the preclinical research sector and regulatory barriers ensure business resilience, making the forward EV/Revenue multiple a key indicator of market confidence. This chart reflects the ratio of the company's current valuation to expected sales, allowing investors to quickly assess whether the asset is overbought or possesses growth potential based on future cash flow dynamics.

Pesaing wigati

Multiplikator Forward P/S IQV (IQVIA)|Rega forward marang dodolan LH|Medpace Inc. - Multiplikator Forward P/S|ICLR - Multiplikator Forward P/S|Evotec SE (EVO) - Rasio rega marang prakiraan pendapatan|fortrea.com - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Lifecore Biomedical Inc.|Rasio rega marang prakiraan pendapatan OABI|Multiplikator Forward P/S NOTV|CDMO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Catalent, Inc. CTLT|Rasio kapitalisasi marang dodolan sing dikarepake nighthawkbio.com (SCPX)